このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

NextGen Healthcare 将来の成長

Future 基準チェック /36

NextGen Healthcareは、41.8%と6.7%でそれぞれ年率41.8%で利益と収益が成長すると予測される一方、EPSはgrowで42.6%年率。

主要情報

41.8%

収益成長率

42.6%

EPS成長率

Healthcare Services 収益成長	26.9%
収益成長率	6.7%
将来の株主資本利益率	n/a
アナリストカバレッジ	Good
最終更新日	25 Oct 2023

今後の成長に関する最新情報

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 27

Recent updates

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

Aug 24

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 27

Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

Jul 13

Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

Dec 08

These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

Oct 27

At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

Sep 30

NextGen Enterprise solution to be used by NY-based health center

Sep 28

NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

Sep 07

NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

Jul 29

NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates

Jul 26

Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

May 17

NextGen At A Crossroads

Oct 13

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?

Jun 29

業績と収益の成長予測

NasdaqGS:NXGN - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2026	824	85	85	131	3
3/31/2025	770	62	73	101	8
3/31/2024	719	39	12	63	8
9/30/2023	695	-6	-43	-8	N/A
6/30/2023	678	2	4	40	N/A
3/31/2023	653	-3	6	44	N/A
12/31/2022	626	23	16	53	N/A
9/30/2022	614	20	32	67	N/A
6/30/2022	604	0	18	49	N/A
3/31/2022	596	2	25	54	N/A
12/31/2021	589	1	31	59	N/A
9/30/2021	581	-4	42	71	N/A
6/30/2021	572	13	53	81	N/A
3/31/2021	557	10	70	99	N/A
12/31/2020	549	6	72	97	N/A
9/30/2020	545	10	68	93	N/A
6/30/2020	539	5	62	86	N/A
3/31/2020	540	7	59	86	N/A
12/31/2019	539	16	53	82	N/A
9/30/2019	532	16	49	76	N/A
6/30/2019	528	23	37	64	N/A
3/31/2019	529	24	25	50	N/A
12/31/2018	530	10	26	52	N/A
9/30/2018	531	6	24	51	N/A
6/30/2018	533	1	35	63	N/A
3/31/2018	531	2	45	74	N/A
12/31/2017	528	18	57	84	N/A
9/30/2017	524	27	67	92	N/A
6/30/2017	518	23	N/A	111	N/A
3/31/2017	510	18	N/A	110	N/A
12/31/2016	505	-2	N/A	95	N/A
9/30/2016	494	-6	N/A	83	N/A
6/30/2016	493	-1	N/A	50	N/A
3/31/2016	492	6	N/A	41	N/A
12/31/2015	493	33	N/A	51	N/A
9/30/2015	499	32	N/A	54	N/A
6/30/2015	494	29	N/A	68	N/A
3/31/2015	490	27	N/A	83	N/A
12/31/2014	477	22	N/A	91	N/A
9/30/2014	462	3	N/A	103	N/A
6/30/2014	453	8	N/A	91	N/A
3/31/2014	445	16	N/A	104	N/A
12/31/2013	441	6	N/A	95	N/A
9/30/2013	446	35	N/A	82	N/A
6/30/2013	451	40	N/A	80	N/A
3/31/2013	460	43	N/A	68	N/A
12/31/2012	458	62	N/A	61	N/A

アナリストによる今後の成長予測

収入対貯蓄率: NXGNは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.2% ) よりも高い成長率であると考えられます。

収益対市場: NXGN今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: NXGN今後 3 年以内に収益を上げることが予想されます。

収益対市場: NXGNの収益 ( 6.7% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: NXGNの収益 ( 6.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: NXGNの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

NextGen Healthcare 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target increased by 7.0% to US$21.68

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

NextGen Healthcare, Inc. Revises Financial Guidance for the Fiscal Year 2024

Price target decreased by 8.0% to US$20.25

NextGen Healthcare, Inc. Provides Revenue Guidance for the Fiscal Year 2024

Consensus EPS estimates increase by 88%

Recent updates

NextGen Healthcare Expands Capabilities of NextGen®? Ambient Assist and Introduces Tailored Solution for Small Practices, NextGen®? Office Ambient Assist

NextGen Healthcare, Inc. Bolsters C-Suite with Three Industry Veterans

NextGen Healthcare Launches Ai-Driven Efficiency Solution for Mental and Behavioral Health Professionals

NextGen Healthcare, Inc. Files Form 15

Thoma Bravo Discover Fund IV, managed by Thoma Bravo, L.P. completed the acquisition of NextGen Healthcare, Inc. (NasdaqGS:NXGN) from shareholders.

NextGen Healthcare, Inc. Unveils NextGen Ambient Assist, an AI Solution Designed to Boost Provider Efficiency

Thoma Bravo Discover Fund IV, managed by Thoma Bravo, L.P. entered into a definitive agreement to acquire NextGen Healthcare, Inc. (NasdaqGS:NXGN) from shareholders for $1.6 billion.

Price target increased by 7.0% to US$21.68

Thoma Bravo Reportedly in Advanced Talks to Buy NextGen Healthcare

NextGen Healthcare Reportedly Explores Sale

Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?

NextGen Healthcare, Inc., Annual General Meeting, Aug 22, 2023

NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

NextGen Healthcare, Inc. Revises Financial Guidance for the Fiscal Year 2024

NextGen Healthcare, Inc. Enters into Settlement Agreement with the U.S. Department of Justice and Two Private Parties

Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist

NextGen Healthcare, Inc. to Report Q1, 2024 Results on Jul 24, 2023

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

Price target decreased by 8.0% to US$20.25

Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

NextGen Healthcare, Inc. Provides Revenue Guidance for the Fiscal Year 2024

What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?

We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease

NextGen Healthcare, Inc. Announces Resignation of David A. Metcalfe as Executive Vice President & Chief Technology Officer

Consensus EPS estimates increase by 88%

Third quarter 2023 earnings: EPS exceeds analyst expectations

NextGen Healthcare, Inc. Revises Earnings Guidance for the Year 2023

NextGen Healthcare, Inc. to Report Q3, 2023 Results on Jan 24, 2023

Now 21% undervalued

Executive VP & CFO exercised options and sold US$533k worth of stock

Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value

Consensus forecasts updated

Executive VP & CTO exercised options and sold US$132k worth of stock

NextGen Healthcare, Inc. (NasdaqGS:NXGN) acquired TSI Healthcare, Inc. for $90 million.

NextGen Healthcare, Inc. (NasdaqGS:NXGN) acquired TSI Healthcare, Inc. for $90 million.

Executive VP & CTO exercised options and sold US$194k worth of stock

These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong

NextGen Healthcare, Inc. Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

NextGen Healthcare, Inc. (NasdaqGS:NXGN) announces an Equity Buyback for $100 million worth of its shares.

NextGen Healthcare, Inc. to Report Q2, 2023 Results on Oct 25, 2022

At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?

CEO, President & Director exercised options and sold US$414k worth of stock

NextGen Enterprise solution to be used by NY-based health center

NextGen Healthcare, Inc Announces New Foster Care Functionality in Behavioral Health Suite

NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price

Planet DDS, Inc. acquired NXGN Management LLC from NextGen Healthcare, Inc. (NasdaqGS:NXGN).

NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital

NextGen Healthcare, Inc. Revises Earnings Guidance for the Year 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates

NextGen Healthcare, Inc. to Report Q1, 2023 Results on Jul 26, 2022

Independent Vice Chairman notifies of intention to sell stock

NextGen Healthcare, Inc., Annual General Meeting, Aug 17, 2022

NextGen Healthcare, Inc. Launches Health Data Hub Insights

Consensus forecasts updated

Full year 2022 earnings: EPS misses analyst expectations

NextGen Healthcare, Inc. Provides Earnings Guidance for the Fiscal Year 2023

Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?

NextGen Healthcare, Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter and Full Year Ended March 31, 2022 and for the Fiscal Year 2023

Consensus forecasts updated

Executive VP & CTO exercised options and sold US$200k worth of stock

Nextgen Healthcare Releases Latest EHR Tool for Behavioral Health, Human Services

Independent Vice Chairman notifies of intention to sell stock

NextGen Healthcare Unveils Latest Solution for Behavioral Health and Human Services

Insider exercised options and sold US$315k worth of stock

Consensus forecasts updated